# Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention

Study · id `cardio:ct-nct04748068` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04748068](<https://clinicaltrials.gov/study/NCT04748068>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04748068

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT04748068. Randomized; single masking; primary purpose prevention. Start 2021-02-01 (anticipated); primary completion 2021-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT04748068, source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)
- Planned start: 2021-02-01 (anticipated) (ClinicalTrials.gov record NCT04748068, source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)
- Primary completion: 2021-05-31 (anticipated) (ClinicalTrials.gov record NCT04748068, source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)
- Completion: 2021-05-31 (anticipated) (ClinicalTrials.gov record NCT04748068, source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04748068, source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04748068-2021-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention
- Condition: Radial Artery Occlusion
- Condition: Coronary Artery Disease
- Intervention (Device): 7-Fr Glidesheath Slender
- Intervention (Device): Cordis 7-Fr radial sheath
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)

## Provenance

Content hash: 9d2d3c50a885430fc4f6cbeeb37c01b1989fb329a180566d9f521326cbde90d8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
